7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Jasper Therapeutics, Inc.
(NASDAQ:JSPR) 

JSPR stock logo

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell trans...

Founded: 2019
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Jasper Therapeutics . Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0165.27330.54495.82661.09826.36991.631,156.9
Jasper Therapeutics . Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 06.3512.7119.0625.4131.7638.1244.47
Jasper Therapeutics . Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 025.1550.3175.46100.62125.77150.93176.08
Jasper Therapeutics . Op Cashflow Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.71-4.04-3.37-2.69-2.02-1.35-0.670
Jasper Therapeutics . Free Cashflow Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.74-4.06-3.38-2.71-2.03-1.35-0.680
Jasper Therapeutics . Cash Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.122.253.374.55.626.747.87
Jasper Therapeutics . P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 030.9461.8792.81123.75154.69185.62216.56
Jasper Therapeutics . (GAAP) P/E ratio ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -38.94-33.38-27.82-22.25-16.69-11.13-5.560
Jasper Therapeutics . P/B ratio ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.687.3511.0314.7118.3822.0625.74
No extra charts and metrics for this ticker.